These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 9416842)

  • 1. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
    Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
    Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
    Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
    Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
    Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opposite effect of p53 on nucleotide metabolizing enzyme activity in Rat1 cells and their sublines, transformed by N-RAS or v-mos oncogenes].
    Khramtsova SN; Osovskaia VS; Semeniak OIu; Potapova GI; Chumakov PM; Kopnin BP
    Biokhimiia; 1995 Nov; 60(11):1881-8. PubMed ID: 8590759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints.
    Agapova LS; Ivanov AV; Sablina AA; Kopnin PB; Sokova OI; Chumakov PM; Kopnin BP
    Oncogene; 1999 May; 18(20):3135-42. PubMed ID: 10340385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
    Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
    Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphology, cell-cell interactions, and migratory activity of IAR-2 epithelial cells transformed with the RAS oncogene: contribution of cell adhesion protein E-cadherin].
    Zhitniak IIu; Glushankova NA
    Ontogenez; 2011; 42(6):453-64. PubMed ID: 22288108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization.
    Alexandrova A; Ivanov A; Chumakov P; Kopnin B; Vasiliev J
    Oncogene; 2000 Nov; 19(50):5826-30. PubMed ID: 11126371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
    Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
    Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of epithelial and fibroblast-like cells to discontinuous configuration of the culture substrate.
    Rovensky YuA ; Domnina LV; Ivanova OYu ; Vasiliev JM
    Membr Cell Biol; 2001 Jul; 14(5):617-27. PubMed ID: 11699865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The protective role of p53 in Ras-induced transformation of REF52 cells].
    Kopnin PB; Ivanov AV; Il'inskaia GV; Sablina AA; Kopnin BP; Chumakov PM
    Mol Biol (Mosk); 2003; 37(3):458-71. PubMed ID: 12815953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
    Yam JW; Chan KW; Hsiao WL
    Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
    Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cylindrical substratum induces different patterns of actin microfilament bundles in nontransformed and in ras-transformed epitheliocytes.
    Levina EM; Domnina LV; Rovensky YA; Vasiliev JM
    Exp Cell Res; 1996 Nov; 229(1):159-65. PubMed ID: 8940260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation by RAS oncogene decreases the width of substrate-spread fibroblasts but not their length.
    Kharitonova MA; Kopnin PB; Vasiliev JM
    Cell Biol Int; 2007 Mar; 31(3):220-3. PubMed ID: 17142064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.